Stocks and Investing
Stocks and Investing
Mon, October 24, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jessica Fye Maintained (BNTX) at Hold with Decreased Target to $132 on, Oct 24th, 2022
Jessica Fye of JP Morgan, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $183 to $132 on, Oct 24th, 2022.
Jessica has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 1 agrees with Jessica's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $194 on, Friday, July 15th, 2022
These are the ratings of the 3 analyists that currently disagree with Jessica
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $272 on, Wednesday, August 10th, 2022
- Daina Graybosch of "SVB Leerink" Maintained at Buy with Increased Target to $224 on, Friday, July 29th, 2022
- William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $192 on, Wednesday, July 6th, 2022
Contributing Sources